Okay, so this article talks about some important people who work with a plant called cannabis, which some people use as medicine or enjoy for fun. The world is changing and more countries are allowing the use of cannabis, so these people are becoming very successful and famous. The article lists two big companies that do well in this business: Curaleaf Holdings and Tilray Brands. They both make a lot of money by growing and selling cannabis in different parts of the world. Some countries like Germany still have some rules about using cannabis, but they might change soon too. Read from source...

1. The article starts with a quote from Fortune Business Insights that provides an optimistic forecast for the global cannabis market size by 2030, but does not provide any sources or evidence to support their claim. This is a common technique used by clickbait articles to grab the reader's attention without providing any factual basis.
2. The article mentions Europe as a key player in the global cannabis sector with significant potential for opportunities, but does not elaborate on which countries are leading the way or what specific policies are driving this growth. This is a vague and general statement that lacks depth and detail.
3. The article states that Germany continues to delay its most recent policies, but does not explain why this is a problem or how it affects the overall market. This is an emotional argument that appeals to the reader's frustration without providing any logical reasoning or facts.

Based on the article you provided, it seems that there are several international cannabis companies that have been performing well or have potential for growth in the global market. Here is a summary of some of them:

- Curaleaf Holdings (OTC:CURLF): This company has operations in Europe and the U.S., as well as a strong brand portfolio and a diversified product portfolio. It also has a strategic partnership with Tilray Brands, which gives it access to new markets and products. Curaleaf is one of the largest cannabis companies by revenue and market capitalization, and it has been expanding its retail footprint and capacity across multiple states in the U.S. Some potential risks for this company include regulatory uncertainty in Europe, competition from other large players, and high valuation compared to peers.
- Tilray Brands (NASDAQ:TLRY): This is a leading global cannabis company with operations in North America, Europe, Australia, and Latin America. It has a broad product portfolio that includes medical and adult-use cannabis, hemp products, beverages, edibles, and vape devices. Tilray also has partnerships with several well-known brands, such as Anheuser-Busch InBev (NYSE:BUD) for non-alcoholic beverages and Sandoz, a Novartis (NYSE:NVS) division, for medical cannabis in Canada. Some of the risks for this company include high debt levels, intense competition, regulatory hurdles, and exposure to emerging markets with uncertain demand.
- Other companies that are mentioned or implied in the article include Canopy Growth (NASDAQ:CGC), Aphria (NASDAQ:APHA), Aurora Cannabis (NASDAQ:ACB), and Cronos Group (NASDAQ:CRON). These companies also have operations in multiple countries, but they may face different challenges depending on their strategies, markets, and products.

Therefore, based on the article, I would recommend that you consider investing in Curaleaf Holdings or Tilray Brands as they seem to have a strong position in the global cannabis market with diversified product portfolios and partnerships. However, you should also be aware of the risks involved, such as regulatory changes, competition, valuation, debt, and market volatility. You may want to consult with a financial advisor or do further research before making any decisions.